Latest filing published 26 Jun 2023 for 派林生物, €9.8M.
All filings by 杨莉 on record concern 派林生物, in the capacity of board member. Over a trading history stretching from 13 December 2022 to 26 June 2023, the count stands at 2 filings.
The open-market record consists of 2 sales worth €15.8M, with no purchase. Since January 2023: no purchases and 1 sale on the market.
The latest filing, published on 26 June 2023, reports an open-market sale of €9.8M in 派林生物. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.